CLTS — Earth Life Sciences Cashflow Statement

0.000.00%

Last trade - 00:00

TechnologyHighly SpeculativeMicro Cap

Annual cashflow statement for Earth Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2017 December 31st	2018 December 31st	2019 December 31st	C2020 December 31st	2021 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	—	—	—	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-6.79	-0.438	-0.054	-1.82	-1.58
Depreciation
Non-Cash Items	6.75	0.399	—	1.79	1.54
Other Non-Cash Items
Changes in Working Capital	0.038	0.038	0.053	0.01	0.026
Change in Prepaid Expenses
Change in Accounts Payable
Change in Payable / Accrued Expenses
Cash from Operating Activities	0	0	0	-0.025	-0.016
Other Investing Cash Flow Items	0	0	0	0	0
Other Investing Cash Flow
Cash from Investing Activities	0	0	0	0	0
Financing Cash Flow Items	0	0.062	0	0.025	0.016
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities	0	0	0	0.025	0.016
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0	0	0	0	0